Company Filing History:
Years Active: 2020-2025
Title: Mary Kerr - Innovator in Pharmaceutical Formulations
Introduction
Mary Kerr is a notable inventor based in Stevenage, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of menopause and pulmonary fibrosis. With a total of 6 patents to her name, her work has the potential to impact many lives.
Latest Patents
One of her latest patents is focused on a method of treatment for symptoms of menopause. This invention relates to novel pharmaceutical formulations containing 2-[3,5-Bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxymethyl) hexahydropyrazino [2,1-c] [1,4]oxazin-8(1H)-yl]-3-pyridinyl}-N,2-dimethylpropanamide. Additionally, she has developed a new use for neurokinin-1 receptor antagonists as a treatment for pulmonary fibrosis conditions that are promoted by mechanical injury to the lungs. This includes injuries induced by mechanical ventilation or coughing in patients with pulmonary fibrosis.
Career Highlights
Throughout her career, Mary has worked with various companies, including Kandy Therapeutics Limited and Nerre Therapeutics Limited. Her innovative approaches and dedication to research have established her as a respected figure in her field.
Collaborations
Mary has collaborated with professionals such as Mike Trower and Monica Lazaro, contributing to her success and the advancement of her projects.
Conclusion
Mary Kerr's contributions to pharmaceutical innovations demonstrate her commitment to improving medical therapies. Her patents reflect her expertise and dedication to addressing significant health challenges.